Medable is partnering with Withings Health Solutions to use the company's connected devices for decentralized clinical trials.
The collaboration will allow Withings' tools for remote monitoring, like connected scales, blood pressure monitors and sleep-tracking mats, to collect patient data and integrate with Medable's clinical trial platform.
"As the industry leader in plug-and-play connected...
The Digital Medicine Society (DiMe) on Monday revealed four toolkits to help healthcare and life science organizations use data from sensors like wearables and remote patient monitoring systems at scale.
The four toolkits are based on resources derived from the society's Sensor Data Integrations project, which includes organizations like Amazon Web Services, Oracle, the Moffitt Cancer Center,...
Digital cancer care company Kaiku Health has entered into a strategic partnership with pharma and diagnostics giant Roche to offer Kaiku's tools for symptom management and support to clinics and patients.
Finnish-born Kaiku provides a digital platform where patients can input their symptoms as they undergo cancer treatment, receive feedback for lower-acuity concerns and keep the care team...
Prescription digital therapeutics startup MedRhythms has entered into a licensing agreement with Biogen to develop and commercialize its MR-004 product, which aims to improve mobility for people with multiple sclerosis (MS).
Under the deal, MedRhythms would receive a $3 million upfront payment from Biogen, with the potential to earn up to $117.5 million if certain development and commercial...
The Digital Medicine Society (DiMe) teamed up with a slew of pharma giants and payers to launch a digital endpoints toolkit for stakeholders.
The open-access toolkit, which came from a partnership between DiMe, Anthem, Biogen, Eli Lilly, Evidation, Janssen, Merck, Pfizer and Savvy Co-op, gives payers a road map for including digital endpoints in reimbursement for new drugs. Dubbed the 3Ps toolkit...
ORLANDO, Fla. – While technology continues to propel clinical trials, research in the U.S. still lacks accurate representation of the country.
"What we know is that race and ethnicity are social constructs and are not dependent on our genes," Jennifer Jones-McMeans, divisional vice president of global clinical affairs for Abbott’s vascular business, said during a HIMSS22 session. "When we look...
Medication adherence has been a historical challenge in healthcare. In fact, according to a study published in the Permanente Journal, medication nonadherence causes approximately 125,000 avoidable deaths each year.
But new technologies and an increasing focus on the patient experience could help curb this issue.
MobiHealthNews asked the University of Pittsburgh Medical Center's chief pharmacy...
Germany’s Bayer has launched Saudi Arabia’s first “digital hub” to improve management of pulmonary hypertension (PH), it has announced.
The AAN Digital Hub – reportedly designed to address gaps in diagnosis and treatment of the condition during the COVID-19 pandemic – focuses on facilitating virtual referrals for patients, as well as enabling knowledge exchange between primary physicians and...
Artificial intelligence could potentially disrupt nearly every industry. Pharma giants have continued to take note. From AI in drug discovery to digital therapeutics, big name life science companies have invested time and money into the space.
However, big tech's move fast and break things mentality doesn't always align with pharma's regulated model. Today a number of accelerators and labs are...
_18.jpg?itok=q487l_qs "Businesspeople shaking hands")
_10.JPG?itok=Bh1y0ed4)
_9.JPG?itok=yNwUpNTb)
